Skip to main content
. Author manuscript; available in PMC: 2021 Jul 9.
Published in final edited form as: ACS Appl Bio Mater. 2020 Dec 24;4(1):229–251. doi: 10.1021/acsabm.0c01145

Figure 2.

Figure 2.

Passive and active targeting mechanisms. (a) Drug (yellow) loaded nanoparticles entering tumor cells through leaky vasculature. (b) Drug loaded nanoparticles entering tumor cells using receptor mediated targeting.